Showing: 1 - 2 of 2 RESULTS

Simulations Plus, University of Health Sciences and Pharmacy in St. Louis secure new grant from USFDA (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) through a joint proposal with the St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis has been awarded a new funded cooperative agreement from the USFDA.

Both to establish novel in vitro/in silico models for the oral cavity route of administration in GastroPlus to accelerate pharmaceutical research and regulatory assessment of innovative and generic drug products delivered intraorally.

Press Release

Source Article

Simulations Plus, University of Health Sciences and Pharmacy in St. Louis secures new grant from USFDA (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) through a joint proposal with the St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis, it has been awarded a new funded cooperative agreement from the USFDA.

Both to establish novel in vitro/in silico models for the oral cavity route of administration in GastroPlus® to accelerate pharmaceutical research and regulatory assessment of innovative and generic drug products delivered intraorally.

Press Release

Source Article